Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin (Q37214596)

19 August 2017

Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin (English)

1 reference

19 August 2017

Sergio Peralta

1

1 reference

19 August 2017

Claudia Cottone

2

1 reference

19 August 2017

Tiziana Doveri

3

1 reference

19 August 2017

Piero Luigi Almasio

4

1 reference

19 August 2017

Antonio Craxi

5

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 June 2009

1 reference

World Journal of Gastroenterology

19 August 2017

1 reference

19 August 2017

15

1 reference

19 August 2017

21

1 reference

19 August 2017

2628-2631

1 reference

Bacterial overgrowth syndrome in the small intestine: pathogenesis, clinical significance and therapy tactics

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Microecological aspects of small intestinal bacterial overgrowth syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Treatment of small intestine bacterial overgrowth.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Management of small intestinal bacterial overgrowth

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Small intestine bacterial overgrowth: six case reports and literature review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Non-absorbable antibiotics and small bowel bacterial overgrowth.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Breath tests in the diagnosis of small intestine bacterial overgrowth

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Anaerobic bacteria as cause of the blind loop syndrome. A case report with observations on response to antibacterial agents.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2691494

Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial

3 September 2018

1 reference

12 December 2020

Efficacy of massive dose oral gentamicin therapy in nonbloody persistent diarrhea with associated malnutrition

1 reference

12 December 2020

[Guidelines on intestinal dysmicrobism (SIBO Small Intestine Bacterial Overgrowth)]

1 reference

12 December 2020

Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin

1 reference

12 December 2020

[Therapeutic study of the effect of selective decontamination on microbial overgrowth syndrome of the small intestine]

1 reference

12 December 2020

Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.15.2628

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19496193

1 reference